156 Epizód

  1. Inhaled budesonide in the treatment of early COVID-19

    Közzétéve: 2021. 04. 15.

  2. Tocilizumab and COVID-19

    Közzétéve: 2021. 03. 05.

  3. Interferon treatment and COVID-19

    Közzétéve: 2021. 02. 06.

  4. Evaluating deterioration in patients with acute COVID-19

    Közzétéve: 2021. 01. 12.

  5. Treatment options in patients with systemic sclerosis-associated interstitial lung disease

    Közzétéve: 2021. 01. 05.

  6. COVID-19 and severe influenza

    Közzétéve: 2020. 12. 18.

  7. The second wave and homeless populations

    Közzétéve: 2020. 11. 11.

  8. Corticosteroids, COPD, asthma and COVID-19

    Közzétéve: 2020. 09. 25.

  9. Novel strategies to drive down the global burden of asthma

    Közzétéve: 2020. 09. 08.

  10. The pathology of suspected EVALI

    Közzétéve: 2020. 08. 05.

  11. Wheezing illness and RSV-LRTI

    Közzétéve: 2020. 07. 17.

  12. Antibiotic use in infancy and asthma incidence

    Közzétéve: 2020. 03. 16.

  13. Guidance on the development of prediction models for critical care

    Közzétéve: 2020. 03. 12.

  14. Potential exacerbations in patients with COPD

    Közzétéve: 2020. 03. 03.

  15. CPAP and mild obstructive sleep apnea

    Közzétéve: 2019. 11. 28.

  16. An algorithm for EVALI

    Közzétéve: 2019. 11. 08.

  17. Lung transplants from Hepatitis C viremic donors

    Közzétéve: 2019. 10. 05.

  18. Looking to the future of cystic fibrosis care

    Közzétéve: 2019. 09. 29.

  19. Pamrevlumab and idiopathic pulmonary fibrosis

    Közzétéve: 2019. 09. 27.

  20. Nicotine patches, e-cigarettes, and smoking cessation

    Közzétéve: 2019. 09. 10.

3 / 8

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

Visit the podcast's native language site